Clinical Trials List
2023-08-01 - 2026-07-31
Phase II
Recruiting1
ICD-10D82.2
Immunodeficiency with short-limbed stature
ICD-10D82.3
Immunodeficiency following hereditary defective response to Epstein-Barr virus
ICD-10D82.4
Hyperimmunoglobulin E [IgE] syndrome
ICD-10D82.8
Immunodeficiency associated with other specified major defects
ICD-10D82.9
Immunodeficiency associated with major defect, unspecified
ICD-10D84.0
Lymphocyte function antigen-1 [LFA-1] defect
ICD-10D84.1
Defects in the complement system
ICD-10D89.3
Immune reconstitution syndrome
ICD-10D89.89
Other specified disorders involving the immune mechanism, not elsewhere classified
ICD-10M35.9
Systemic involvement of connective tissue, unspecified
ICD-9279.8
Other specified disorders involving the immune mechanism
-
Trial Applicant
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- Gigin Lin Division of Radiology
- Chao-Wei Hsu Digestive System Department
- 陳怡文 Division of Endocrinology
- Wen-Cheng Chang Division of Hematology & Oncology
- Ming-Mo Hou Division of Hematology & Oncology
- 謝憬儀 無
- Chun-Bing Chen Division of Dermatology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
30 participants
